Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats

被引:11
作者
Shen, FM [1 ]
Xie, HH [1 ]
Ling, G [1 ]
Xu, LP [1 ]
Su, DF [1 ]
机构
[1] Second Mil Med Univ, Dept Pharmacol, Shanghai 200433, Peoples R China
关键词
atenolol; amlodipine; blood pressure; blood pressure variability; hypertension;
D O I
10.1111/j.1745-7254.2005.00185.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To test the synergistic effects of atenolol and amlodipine on lowering blood pressure (BP) and reducing blood pressure variability (BPV) in 2-kidney, one-clip (2K1C) renovascular hypertensive rats. Methods: Forty-eight 2K1C renovascular hypertensive rats were randomly divided into 6 groups. They were respectively given 0.8% carboxymethylcellulose sodium (control), atenolol (10.0 mg/kg), amlodipine (1.0 mg/kg), and combined atenolol and amlodipine (low dose: 5.0+0.5 mg/kg; intermediate dose: 10.0+1.0 mg/kg; high dose: 20.0+2.0 mg/kg). The drugs were given via a catheter in a gastric fistula. BP was recorded for 25 h from 1 h before drug administration to 24 h after administration. Results: Compared with BP before medication, all 3 doses of combined atenolol and amlodipine significantly decreased the BP at 24 h after administration, except for the low dose on diastolic BP. Compared with the control group, all 3 doses of combined atenolol and amlodipine significantly reduced the average BP levels for the 24 h period after administration; furthermore, the high and intermediate doses also significantly decreased the BPV levels for the same period. The q values calculated by probability sum analysis for systolic and diastolic BP for the 24 h period after administration were 2.29 and 1.45, respectively, and for systolic and diastolic BPV for the same period they were 1.41 and 1.60, respectively. Conclusion: There is significant synergism between atenolol and amlodipine in lowering and stabilizing BP in 2K1C renovascular hypertensive rats.
引用
收藏
页码:1303 / 1308
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[2]  
Black HR, 1998, ARCH INTERN MED, V158, P573
[3]   Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats [J].
Du, WM ;
Miao, CY ;
Liu, JG ;
Shen, FM ;
Yang, XQ ;
Su, DF .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (02) :233-239
[4]   THE EFFECT OF PRESCRIBED DAILY DOSE FREQUENCY ON PATIENT MEDICATION COMPLIANCE [J].
EISEN, SA ;
MILLER, DK ;
WOODWARD, RS ;
SPITZNAGEL, E ;
PRZYBECK, TR .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (09) :1881-1884
[5]   ANGIOTENSIN AND ANGIOTENSIN CONVERTING ENZYME TISSUE-LEVELS IN 2-KIDNEY, ONE CLIP HYPERTENSIVE RATS [J].
GUAN, S ;
FOX, J ;
MITCHELL, KD ;
NAVAR, LG .
HYPERTENSION, 1992, 20 (06) :763-767
[6]  
Jin ZJ, 2004, ACTA PHARMACOL SIN, V25, P146
[7]   Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture [J].
Lu, ZA ;
Xie, HH ;
Xu, LP ;
Yin, AF ;
Miao, CY ;
Su, DF .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (1-2) :49-54
[8]   BLOOD-PRESSURE AND HEART-RATE VARIABILITIES IN NORMOTENSIVE AND HYPERTENSIVE HUMAN-BEINGS [J].
MANCIA, G ;
FERRARI, A ;
GREGORINI, L ;
PARATI, G ;
POMIDOSSI, G ;
BERTINIERI, G ;
GRASSI, G ;
DIRIENZO, M ;
PEDOTTI, A ;
ZANCHETTI, A .
CIRCULATION RESEARCH, 1983, 53 (01) :96-104
[9]  
Mancia G, 1994, J Cardiovasc Pharmacol, V24 Suppl A, pS6
[10]   SINGLE-DRUG THERAPY FOR HYPERTENSION IN MEN - A COMPARISON OF 6 ANTIHYPERTENSIVE AGENTS WITH PLACEBO [J].
MATERSON, BJ ;
REDA, DJ ;
CUSHMAN, WC ;
MASSIE, BM ;
FREIS, ED ;
KOCHAR, MS ;
HAMBURGER, RJ ;
FYE, C ;
LAKSHMAN, R ;
GOTTDIENER, J ;
RAMIREZ, EA ;
HENDERSON, WG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (13) :914-921